Literature DB >> 1924389

Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor.

D Maglione1, V Guerriero, G Viglietto, P Delli-Bovi, M G Persico.   

Abstract

A human cDNA coding for a protein related to the vascular permeability factor (VPF) was isolated from a term placenta cDNA library; we therefore named its product placenta growth factor (PlGF). PlGF is a 149-amino-acid-long protein and is highly homologous (53% identity) to the platelet-derived growth factor-like region of human VPF. Computer analyses reveal a putative signal peptide and two probable N-glycosylation sites in the PlGF protein, one of which is also conserved in human VPF. By using N-glycosidase F, tunicamycin, and specific antibodies produced in both chicken and rabbit, we demonstrate that PlGF, derived from transfected COS-1 cells, is actually N-glycosylated and secreted into the medium. In addition, PlGF, like VPF, proves to be a dimeric protein. Finally, a conditioned medium from COS-1 cells containing PlGF is capable of stimulating specifically the growth of CPA, a line of endothelial cells, in vitro.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1924389      PMCID: PMC52695          DOI: 10.1073/pnas.88.20.9267

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  Mechanisms of angiogenesis.

Authors:  P A D'Amore; R W Thompson
Journal:  Annu Rev Physiol       Date:  1987       Impact factor: 19.318

Review 2.  Angiogenic factors.

Authors:  J Folkman; M Klagsbrun
Journal:  Science       Date:  1987-01-23       Impact factor: 47.728

3.  Effect of tunicamycin on the secretion of serum proteins by primary cultures of rat and chick hepatocytes. Studies on transferrin, very low density lipoprotein, and serum albumin.

Authors:  D K Struck; P B Siuta; M D Lane; W J Lennarz
Journal:  J Biol Chem       Date:  1978-08-10       Impact factor: 5.157

4.  Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.

Authors:  A B Roberts; M B Sporn; R K Assoian; J M Smith; N S Roche; L M Wakefield; U I Heine; L A Liotta; V Falanga; J H Kehrl
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  SV40-transformed simian cells support the replication of early SV40 mutants.

Authors:  Y Gluzman
Journal:  Cell       Date:  1981-01       Impact factor: 41.582

7.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

Review 8.  Tumor angiogenesis.

Authors:  J Folkman
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

9.  Structural requirements of N-glycosylation of proteins. Studies with proline peptides as conformational probes.

Authors:  E Bause
Journal:  Biochem J       Date:  1983-02-01       Impact factor: 3.857

10.  Angiogenic and growth factors in human amnio-chorion and placenta.

Authors:  H Burgos
Journal:  Eur J Clin Invest       Date:  1983-08       Impact factor: 4.686

View more
  201 in total

Review 1.  Glucose, VEGF-A, and diabetic complications.

Authors:  L E Benjamin
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

Review 2.  Effect of inflammatory cytokines on the expression of the vascular endothelial growth factor-C.

Authors:  K Narko; B Enholm; T Mäkinen; A Ristimäki
Journal:  Int J Exp Pathol       Date:  1999-06       Impact factor: 1.925

3.  Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor/vascular endothelial growth factor receptor.

Authors:  Rizwan Masood; Ethel Cesarman; D Lynne Smith; Parkash S Gill; Ornella Flore
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

Review 4.  Role of vascular permeability factor/vascular endothelial growth factor in eye disease.

Authors:  R O Schlingemann; V W van Hinsbergh
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

5.  Inhibition of tumor growth, angiogenesis, and microcirculation by the novel Flk-1 inhibitor SU5416 as assessed by intravital multi-fluorescence videomicroscopy.

Authors:  P Vajkoczy; M D Menger; B Vollmar; L Schilling; P Schmiedek; K P Hirth; A Ullrich; T A Fong
Journal:  Neoplasia       Date:  1999-04       Impact factor: 5.715

6.  Recent insights into the pathophysiology of preeclampsia.

Authors:  Eric M George; Joey P Granger
Journal:  Expert Rev Obstet Gynecol       Date:  2010-09-01

7.  Vascular endothelial growth factor and angiopoietin are required for prostate regeneration.

Authors:  Gui-Min Wang; Bruce Kovalenko; Yili Huang; David Moscatelli
Journal:  Prostate       Date:  2007-04-01       Impact factor: 4.104

8.  CRSBP-1/LYVE-l-null mice exhibit identifiable morphological and functional alterations of lymphatic capillary vessels.

Authors:  S S Huang; I-Hua Liu; Tracy Smith; Maulik R Shah; Frank E Johnson; Jung S Huang
Journal:  FEBS Lett       Date:  2006-10-20       Impact factor: 4.124

9.  Vascular endothelial growth factor C induces angiogenesis in vivo.

Authors:  Y Cao; P Linden; J Farnebo; R Cao; A Eriksson; V Kumar; J H Qi; L Claesson-Welsh; K Alitalo
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

Review 10.  New insights into molecular mechanisms of diabetic kidney disease.

Authors:  Shawn S Badal; Farhad R Danesh
Journal:  Am J Kidney Dis       Date:  2014-02       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.